Publications by authors named "Marion Bossennec"

Claim this Profile
M
MDR1-EXPRESSING CD4 T CELLS WITH TH1.17 FEATURES RESIST TO NEOADJUVANT CHEMOTHERAPY AND ARE ASSOCIATED WITH BREAST CANCER CLINICAL RESPONSE.
Anthony Di Roio, Margaux Hubert, Laurie Besson, Marion Bossennec, Céline Rodriguez

J Immunother Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methotrexate Restores CD73 Expression on Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis Patients and May Contribute to Its Anti-Inflammatory Effect through Ado Production.
Marion Bossennec, Céline Rodriguez, Margaux Hubert, Anthony Di-Roio, Christelle Machon

J Clin Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDR1 in immunity: friend or foe?
Marion Bossennec, Anthony Di Roio, Christophe Caux, Christine Ménétrier-Caux

Oncoimmunology· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autocrine Adenosine Regulates Tumor Polyfunctional CD73CD4 Effector T Cells Devoid of Immune Checkpoints.
Nicolas Gourdin, Marion Bossennec, Céline Rodriguez, Selena Vigano, Christelle Machon

Cancer Res· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FBXO11 inactivation leads to abnormal germinal-center formation and lymphoproliferative disease.
Christof Schneider, Ning Kon, Letizia Amadori, Qiong Shen, Friederike H Schwartz, Marion Bossennec

Blood· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis